Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
25 participants
INTERVENTIONAL
2019-03-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
E-cadherin and Integrin Alpha v Beta 1 in Vitiligo
NCT05287776
Sensory Symptoms in Active Vitiligo
NCT05390164
Expression of Erythroid Differentiation Regulator 1 (Erdr1) in Vitiligo
NCT03377998
Histochemical Study of Vitiligo in Sohag University Hospital Patients
NCT05869942
Insulin Like Growth Factor-1 Against Oxidative Stress in Vitiligo
NCT05812079
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
vitiligo patients
Tissue levels of human beta-defensin 1 in vitiligo patients before and after NB-UVB phototherapy
skin biopsy before and after NB-UVB phototherapy
skin biopsy before and after NB-UVB phototherapy to measure tissue human beta-defensin 1
Healthy controls
Tissue levels of human beta-defensin 1 in healthy controls
skin biopsy before and after NB-UVB phototherapy
skin biopsy before and after NB-UVB phototherapy to measure tissue human beta-defensin 1
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
skin biopsy before and after NB-UVB phototherapy
skin biopsy before and after NB-UVB phototherapy to measure tissue human beta-defensin 1
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both genders.
* Age more than 18 years old.
* New cases or cases not receiving any treatment for at least 3 months prior to the study.
Exclusion Criteria
* Any contraindication to phototherapy treatment.
* History of autoimmune diseases or other systemic diseases.
* Any other skin disease.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maha Fathy Elmasry
principal investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Dermatology 12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.